These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 11168786

  • 1. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
    Bergquist A, Glaumann H, Stål P, Wang GS, Broomé U.
    J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
    [Abstract] [Full Text] [Related]

  • 2. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC.
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC.
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [Abstract] [Full Text] [Related]

  • 4. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A, Glaumann H, Persson B, Broomé U.
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [Abstract] [Full Text] [Related]

  • 5. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
    Kerr SE, Barr Fritcher EG, Campion MB, Voss JS, Kipp BR, Halling KC, Lewis JT.
    Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
    [Abstract] [Full Text] [Related]

  • 6. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
    Zen Y, Quaglia A, Heaton N, Rela M, Portmann B.
    Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
    [Abstract] [Full Text] [Related]

  • 7. Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development.
    Boberg KM, Schrumpf E, Bergquist A, Broomé U, Pares A, Remotti H, Schjölberg A, Spurkland A, Clausen OP.
    J Hepatol; 2000 Mar; 32(3):374-80. PubMed ID: 10735605
    [Abstract] [Full Text] [Related]

  • 8. p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis.
    Rizzi PM, Ryder SD, Portmann B, Ramage JK, Naoumov NV, Williams R.
    Gut; 1996 Feb; 38(2):265-8. PubMed ID: 8801209
    [Abstract] [Full Text] [Related]

  • 9. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
    Boyd S, Vannas M, Jokelainen K, Isoniemi H, Mäkisalo H, Färkkilä MA, Arola J.
    World J Gastroenterol; 2017 Sep 07; 23(33):6147-6154. PubMed ID: 28970730
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E.
    J Hepatol; 2006 Oct 07; 45(4):568-74. PubMed ID: 16879890
    [Abstract] [Full Text] [Related]

  • 11. p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer.
    Ahrendt SA, Rashid A, Chow JT, Eisenberger CF, Pitt HA, Sidransky D.
    J Hepatobiliary Pancreat Surg; 2000 Oct 07; 7(4):426-31. PubMed ID: 11180865
    [Abstract] [Full Text] [Related]

  • 12. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor Heterogeneity.
    Kamp EJCA, Peppelenbosch MP, Doukas M, Verheij J, Ponsioen CY, van Marion R, Bruno MJ, Groot Koerkamp B, Dinjens WNM, de Vries AC.
    Clin Transl Gastroenterol; 2021 Oct 05; 12(10):e00410. PubMed ID: 34608877
    [Abstract] [Full Text] [Related]

  • 13. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
    Igarashi S, Matsubara T, Harada K, Ikeda H, Sato Y, Sasaki M, Matsui O, Nakanuma Y.
    Histopathology; 2012 Aug 05; 61(2):266-76. PubMed ID: 22594685
    [Abstract] [Full Text] [Related]

  • 14. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
    Boyd S, Mustonen H, Tenca A, Jokelainen K, Arola J, Färkkilä MA.
    Scand J Gastroenterol; 2017 Feb 05; 52(2):242-249. PubMed ID: 27806633
    [Abstract] [Full Text] [Related]

  • 15. Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis.
    Martins EB, Fleming KA, Garrido MC, Hine KR, Chapman RW.
    Gastroenterology; 1994 Aug 05; 107(2):537-42. PubMed ID: 8039630
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of MDM2 protein in intrahepatic cholangiocarcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathological features.
    Horie S, Endo K, Kawasaki H, Terada T.
    Virchows Arch; 2000 Jul 05; 437(1):25-30. PubMed ID: 10963376
    [Abstract] [Full Text] [Related]

  • 17. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
    Rupp C, Bode KA, Leopold Y, Sauer P, Gotthardt DN.
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr 05; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
    [Abstract] [Full Text] [Related]

  • 18. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome.
    Jarnagin WR, Klimstra DS, Hezel M, Gonen M, Fong Y, Roggin K, Cymes K, DeMatteo RP, D'Angelica M, Blumgart LH, Singh B.
    J Clin Oncol; 2006 Mar 01; 24(7):1152-60. PubMed ID: 16505435
    [Abstract] [Full Text] [Related]

  • 19. Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation.
    Majeed A, Castedal M, Arnelo U, Söderdahl G, Bergquist A, Said K.
    Scand J Gastroenterol; 2018 Jan 01; 53(1):56-63. PubMed ID: 28990806
    [Abstract] [Full Text] [Related]

  • 20. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK, Karlsen TH, Folseraas T.
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr 01; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.